Syngen Biotech Co (ROCO:8279) Cyclically Adjusted Book per Share: NT$68.84 (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

ROCO:8279 Syngen Biotech Co Ltd ROCO:8279
90 GF Score
Price NT$79.20
GF Value NT$133.20
Valuation Significantly Undervalued
! 3 Warning Signs
View Full Analysis

What is Syngen Biotech Co Cyclically Adjusted Book per Share?

Syngen Biotech Co ROCO:8279 -1.00% 90 Cyclically Adjusted Book per Share is NT$68.84 as of Jun. 2026. GuruFocus rates ROCO:8279 with a GF Score™ of 90/100 and a GF Value™ of NT$133.20 (Significantly Undervalued). The stock has 3 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

Syngen Biotech Co's adjusted book value per share for the three months ended in Jun. 2026 was NT$86.387. Add all the adjusted book value per share for the past 10 years together and divide the count will get our Cyclically Adjusted Book per Share, which is NT$68.84 for the trailing ten years ended in Jun. 2026.

During the past 12 months, Syngen Biotech Co's average Cyclically Adjusted Book Growth Rate was 11.70% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Book Growth Rate using Cyclically Adjusted Book per Share data.

As of today (2026-09-05), Syngen Biotech Co's current stock price is NT$79.20. Syngen Biotech Co's Cyclically Adjusted Book per Share for the quarter that ended in Jun. 2026 was NT$68.84. Syngen Biotech Co's Cyclically Adjusted PB Ratio of today is 1.15.

During the past 13 years, the highest Cyclically Adjusted PB Ratio of Syngen Biotech Co was 3.23. The lowest was 1.17. And the median was 2.17.


Syngen Biotech Co  (ROCO:8279) Cyclically Adjusted Book per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Book per Share may underestimate the company's equity. Cyclically Adjusted PB Ratio can seem to be too high even the actual PB Ratio is low.

For the Cyclically Adjusted PB Ratio, the book value of the past 10 years are inflation-adjusted and averaged. The result is used for P/B calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PB Ratio is also called CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted book value per share of a company over the past 10 years.

Syngen Biotech Co's Cyclically Adjusted PB Ratio of today is calculated as

Cyclically Adjusted PB Ratio=Share Price/Cyclically Adjusted Book per Share
=79.20/68.84
=1.15

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted PB Ratio of Syngen Biotech Co was 3.23. The lowest was 1.17. And the median was 2.17.


Be Aware

Cyclically Adjusted PB Ratio works better for cyclical companies. It gives you a better idea on the company's real book value.


Syngen Biotech Co Cyclically Adjusted Book per Share Related Terms


Syngen Biotech Co Cyclically Adjusted Book per Share Historical Data

* Premium members only.

The historical data trend for Syngen Biotech Co's Cyclically Adjusted Book per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Syngen Biotech Co Cyclically Adjusted Book per Share Chart

Syngen Biotech Co Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Cyclically Adjusted Book per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 50.39 58.28 64.03

Syngen Biotech Co Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Cyclically Adjusted Book per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 61.61 62.64 64.03 66.65 68.84

ROCO:8279 vs VRTX, REGN, MRNA: Cyclically Adjusted Book per Share Comparison

For the Biotechnology subindustry, Syngen Biotech Co's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Syngen Biotech Co Cyclically Adjusted PB Ratio vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Syngen Biotech Co's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where Syngen Biotech Co's Cyclically Adjusted PB Ratio falls into.


ROCO:8279
90GF Score
Syngen Biotech Co Ltd ROCO:8279
Cyclically Adjusted Book per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Syngen Biotech Co Cyclically Adjusted Book per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

What is Cyclically Adjusted Book per Share? How do we calculate Cyclically Adjusted Book per Share?

Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Book per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the book value per share from 2001 through 2010.

We adjusted the 2001 book value per share data with the total inflation from 2001 through 2010 to the equivalent book value in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's book value is $1 a share in 2001, then the 2001's equivalent book value in 2010 is $1.4 a share. If Wal-Mart's book value is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 book value in 2010 is $1.35. So on and so forth, you get the equivalent book value per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Syngen Biotech Co's adjusted Book Value per Share data for the three months ended in Jun. 2026 was:

Adj_Book= Book Value per Share /CPI of Jun. 2026 (Change)*Current CPI (Jun. 2026)
=86.387/333.9520*333.9520
=86.387

Current CPI (Jun. 2026) = 333.9520.

Syngen Biotech Co Quarterly Data

Book Value per Share CPI Adj_Book
201609 26.104 241.428 36.108
201612 27.037 241.432 37.398
201703 27.902 243.801 38.219
201706 28.898 244.955 39.397
201709 31.358 246.819 42.428
201712 32.413 246.524 43.908
201803 32.902 249.554 44.029
201806 33.191 251.989 43.987
201809 35.222 252.439 46.595
201812 37.043 251.233 49.239
201903 38.483 254.202 50.556
201906 38.528 256.143 50.232
201909 51.618 256.759 67.137
201912 55.035 256.974 71.521
202003 53.511 258.115 69.233
202006 56.262 257.797 72.882
202009 58.463 260.280 75.011
202012 60.002 260.474 76.928
202103 57.995 264.877 73.119
202106 60.355 271.696 74.185
202109 62.894 274.310 76.569
202112 65.362 278.802 78.291
202203 63.976 287.504 74.312
202206 67.510 296.311 76.086
202209 70.884 296.808 79.755
202212 73.486 296.797 82.685
202303 71.183 301.836 78.757
202306 73.932 305.109 80.921
202309 76.528 307.789 83.033
202312 78.655 306.746 85.631
202403 75.868 312.332 81.120
202406 77.844 314.175 82.744
202409 80.543 315.301 85.307
202412 82.509 315.605 87.305
202503 79.775 319.799 83.306
202506 82.971 322.561 85.901
202509 86.125 324.800 88.552
202512 87.569 324.054 90.244
202603 83.811 330.213 84.760
202606 86.387 333.952 86.387

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

What does a Cyclically Adjusted Book per Share of NT$68.84 mean?
Syngen Biotech Co (ROCO:8279) has a Cyclically Adjusted Book per Share of NT$68.84 as of Jun. 2026. Cyclically adjusted book value per share represents the company's inflation-adjusted book value per share over a 10-year period. View historical data on Syngen Biotech Co and its competitors.
Is Syngen Biotech Co's Cyclically Adjusted Book per Share too high?
Syngen Biotech Co's current Cyclically Adjusted Book per Share is NT$68.84. Overall, Syngen Biotech Co has a GF Score™ of 90/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Syngen Biotech Co's Cyclically Adjusted Book per Share compare to VRTX and REGN?
Syngen Biotech Co's Cyclically Adjusted Book per Share of NT$68.84 can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted Book per Share for a Biotechnology company?
A good Cyclically Adjusted Book per Share depends on the Biotechnology industry context. However, Cyclically Adjusted Book per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted Book per Share mean?
A high Cyclically Adjusted Book per Share can signal that a stock is expensive relative to its fundamentals. Cyclically adjusted book value per share represents the company's inflation-adjusted book value per share over a 10-year period. View historical data on Syngen Biotech Co and its competitors. Syngen Biotech Co's current Cyclically Adjusted Book per Share is NT$68.84. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Syngen Biotech Co stock overvalued right now?
Based on GuruFocus' analysis, Syngen Biotech Co (ROCO:8279) is currently considered Significantly Undervalued. The stock's GF Value™ is NT$133.20, compared to a current price of NT$79.20 — trading 40.5% below its estimated fair value. The current Cyclically Adjusted Book per Share is NT$68.84. Syngen Biotech Co's overall GF Score™ is 90/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted Book per Share calculated?
Cyclically Adjusted Book per Share is calculated from a company's financial statements. For Syngen Biotech Co (ROCO:8279), the current Cyclically Adjusted Book per Share is NT$68.84 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Syngen Biotech Co (ROCO:8279) Overvalued in 2026?

Based on GuruFocus' analysis, Syngen Biotech Co stock appears to be undervalued. The current stock price of NT$79.20 is trading 40.5% below its estimated GF Value™ of NT$133.20. GuruFocus considers Syngen Biotech Co to be Significantly Undervalued.

Key valuation signals for ROCO:8279:

  • Cyclically Adjusted Book per Share: NT$68.84
  • GF Value™: NT$133.20 vs. price of NT$79.20 (40.5% below fair value)
  • GF Score™: 90/100 with 3 warning signs

No single metric tells the full story. See the ROCO:8279 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Syngen Biotech Co Business Description

Address Building A, NO.154, Kai-Yuan Road, Xinying District, Tainan, TWN, 73055
Syngen Biotech Co Ltd is a biotechnology company. It is engaged in the manufacturing, sales, and trading of microbial pharmaceutical raw materials. It also provides the design and development of health food and biochemical nutrition. The company's products include pharmaceutical ingredients, nutritional ingredients, biology fermentation products, biology agriculture and aquaculture products.
90GF Score

Get the complete analysis for ROCO:8279

Cyclically Adjusted Book per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

NT$79.20
Price
NT$133.20
GF Value